# US 6,730,488 B2 · Immunological materials and methods for detecting dihydropyrimidine dehydrogenase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,488 B2
- Document ID: US6730488B2
- Status: Granted
- Kind: B2
- Application number: 09/854,886
- Filed: 2001-05-14
- Published: 2002-06-13
- Granted: 2004-05-04
- Earliest claimed: 1997-08-22
- Assignees: Roche Diagnostics GmbH
- Inventors: Takashi Yoshikubo; Masami Hasegawa
- Web page: https://patentgrep.com/patent/US6730488B2

## CPC

- C07K 16/40: against enzymes
- G01N 33/573: for enzymes or isoenzymes
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Monoclonal antibodies against dihydropyrimidine dehydrogenase are disclosed. Immunologic assays using the monoclonal antibodies are also disclosed.

## Claims

### Claim 1

An immunoassay for detecting or determining the amount of dihydropyrimidine dehydrogenase in a biological sample which comprises:
contacting a monoclonal antibody that specifically binds to dihydropyrimidine dehydrogenase with a biological sample suspected of having dihydropyrimidine dehydrogenase therein, wherein said monoclonal antibody is produced by a hybridoma cell line selected from the group consisting of hybridoma cell lines 3A5-6-1 (FERM BP-6015), 4B9-12-1 (FERM BP-6016) and 2E2-B3-1-3 (FERM BP-6014);
allowing said monoclonal antibody to specifically bind to any dihydropyrimidine dehydrogenase present in the sample to form an immunoconjugate; and,
qualitatively or quantitatively detecting the presence or absence of the immunoconjugate
wherein the presence of the immunoconjugate is indicative of the presence of dihydropyrimidine dehydrogenase in the biological sample.

### Claim 2 (depends on 1)

The immunoassay according to claim 1 wherein the presence or absence of the immunoconjugate is detected with the aid of a label.

### Claim 3 (depends on 1)

The immunoassay according to claim 1 wherein the monoclonal antibody is adsorbed on a solid support.

### Claim 4

An immunoassay for detecting or determining the amount of dihydropyrimidine dehydrogenase in a biological sample which comprises:
contacting a solid support having adsorbed thereon a monoclonal antibody that specifically binds to dihydropyrimidine dehydrogenase with a biological sample suspected of having dihydropyrimidine dehydrogenase present therein, wherein said monoclonal antibody comprises a monoclonal antibody produced by a hybridoma cell line selected from the group consisting of hybridoma cell lines 3A5-6-1 (FERM BP-6015), 4B9-12-1 (FERM BP-6016) and 2E2-B3-1-3 (FERM BP-6014);
allowing said monoclonal antibody to specifically bind to any dihydropyrimidine dehydrogenase in the sample, thereby forming an immunoconjugate on the solid support; and,
qualitatively or quantitatively detecting the presence or absence of the immunoconjugate on the solid support
wherein the presence of the immunoconjugate on the solid support is indicative of the presence of dihydropyrimidine dehydrogenase in the biological sample.

### Claim 5 (depends on 4)

An immunoassay according to claim 4 wherein the presence or absence of the immunoconjugate on the solid support is detected by:
adding a second antibody that specifically binds to dihydropyrimidine dehydrogenase;
allowing the second antibody to specifically bind with any dihydropyrimidine dehydrogenase present in the immunoconjugate on the solid support to form a sandwiched conjugate; and,
qualitatively or quantitatively detecting the presence or absence of the sandwiched conjugate with the aid of a label
wherein the presence of the sandwiched complex is indicative of the presence of the immunoconjugate on the solid support.

### Claim 6 (depends on 5)

An immunoassay according to claim 5 wherein the present or absence of the sandwiched conjugate is detected by:
adding a third antibody that specifically binds to the second antibody, wherein the third antibody is conjugated with a label thereby forming a labeled complex comprising the label bound to the solid support; and,
determining the presence or the absence of the label bound to the solid support in the labeled complex.

### Claim 7 (depends on 5)

An immunoassay according to claim 5 wherein the second antibody is a monoclonal antibody different from the first monoclonal antibody and wherein the second monoclonal antibody is produced by a hybridoma cell line selected from the group consisting of hybridoma cell lines 3A5-6-1 (FERM BP-6015), 4B9-12-1 (FERM BP-6016) and 2E2-B3-1-3 (FERM BP-6014).

### Claim 8 (depends on 7)

An immunoassay according to claim 7 wherein the first monoclonal antibody is produced from the hybridoma cell line 3A5-6-1 (FERM BP-6015) and the second monoclonal antibody is produced from the hybridoma cell line 4B9-12-1 (FERM BP-6016).

### Claim 9 (depends on 7)

An immunoassay according to claim 7 wherein the first monoclonal antibody is produced from the hybridoma cell line 4B9-12-1 (FERM BP-6016) and the second monoclonal antibody is produced from the hybridoma cell line 3A5-6-1 (FERM BP-6015).

### Claim 10 (depends on 5)

An immunoassay according to claim 5 wherein the second antibody is conjugated with the label.

### Claim 11 (depends on 10)

An immunoassay according to claim 10 wherein the label is selected from the group consisting of an enzyme label, a biotin label, a radioisotope label and a latex particle label.

### Claim 12 (depends on 7)

An immunoassay according to claim 7 wherein the label is selected from the group consisting of an enzyme label, a biotin label and a radioisotope label.

### Claim 13 (depends on 12)

An immunoassay according to claim 12 wherein the label is a radioisotope label.

### Claim 14

An immunoassay for detecting or determining the amount of dihydropyrimidine dehydrogenase in a biological sample which comprises
contacting a solid support having adsorbed thereon a first monoclonal antibody that specifically binds to dihydropyrimidine dehydrogenase with a biological sample suspected of having dihydropyrimidine dehydrogenase present therein, wherein the first monoclonal antibody comprises a monoclonal antibody that crossreacts with a monoclonal antibody produced by a hybridoma cell line selected from the group consisting of hybridoma lines 3A5-6-1 (FERM BP-6015), 4B9-12-1 (FERM BP-6016) and 2E2-B3-1-3 (FERM BP-6014) allowing the monoclonal antibody to specifically bind to any dihydropyrimidine dehydrogenase in the sample, thereby forming an immunoconjugate on the solid support; and,
adding a second antibody that specifically binds to dihydropyrimidine dehydrogenase;
allowing the second antibody to specifically bind with any dihydropyrimidine dehydrogenase present in the immunoconjugate on the solid support to form a sandwiched conjugate; and
qualitatively or quantitatively detecting the presence or absence of the sandwiched conjugate with the aid of a label
wherein the presence of the sandwiched complex is indicative of the presence of the immunoconjugate on the solid support,
wherein the second antibody is a monoclonal antibody different from the first monoclonal antibody and
wherein the second monoclonal antibody is produced by a hybridoma cell line selected from the group consisting of hybridoma cell lines 3A5-6-1 (FERM BP-6015), 4B9-12-1 (FERM BP-6016) and 2E2-B3-1-3 (FERM BP-6014).

### Claim 15 (depends on 14)

An immunoassay according to claim 14 wherein the first monoclonal antibody crossreacts with a monoclonal antibody produced from the hybridoma cell line 3A5-6-1 (FERM BP-6015) and the second monoclonal antibody is produced from the hybridoma cell line 4B9-12-1 (FERM BP-6016).

### Claim 16 (depends on 14)

An immunoassay according to claim 14 wherein the first monoclonal antibody crossreacts with a monoclonal antibody produced from the hybridoma cell line 4B9-12-1 (FERM BP-6016) and the second monoclonal antibody is produced from the hybridoma cell line 3A5-6-1 (FERM BP-6015).
